These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2482541)

  • 21. STAT1 antisense oligonucleotides attenuate the proinflammatory cytokine release of alveolar macrophages in bleomycin-induced fibrosis.
    Fan X; Wang Z
    Cell Mol Immunol; 2005 Jun; 2(3):211-7. PubMed ID: 16212889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Involvement of cellular immunity in pathology. Neuromalaria].
    Canque B
    Bull Soc Pathol Exot; 1992; 85(2):142-5. PubMed ID: 1327351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF.
    Olleros ML; Chavez-Galan L; Segueni N; Bourigault ML; Vesin D; Kruglov AA; Drutskaya MS; Bisig R; Ehlers S; Aly S; Walter K; Kuprash DV; Chouchkova M; Kozlov SV; Erard F; Ryffel B; Quesniaux VF; Nedospasov SA; Garcia I
    Infect Immun; 2015 Sep; 83(9):3612-23. PubMed ID: 26123801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF in autoimmune diseases, graft-versus-host reactions, and pulmonary fibrosis.
    Vassalli P; Grau GE; Piguet PF
    Immunol Ser; 1992; 56():409-30. PubMed ID: 1550870
    [No Abstract]   [Full Text] [Related]  

  • 27. Implications of cytokines in immunopathology: experimental and clinical data.
    Grau GE
    Eur Cytokine Netw; 1990; 1(4):203-10. PubMed ID: 2104242
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor necrosis factor and immunopathology.
    Piguet PF; Grau GE; Vassalli P
    Immunol Res; 1991; 10(2):122-40. PubMed ID: 1717618
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.
    Grau GE; Piguet PF; Vassalli P; Lambert PH
    Immunol Rev; 1989 Dec; 112():49-70. PubMed ID: 2575074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of tumour necrosis factor and other cytokines in immune-mediated vascular pathology.
    Grau GE; Piguet PF; Vassalli P; Lambert PH
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):34-9. PubMed ID: 2651318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.
    Ansar M; Serrano D; Papademetriou I; Bhowmick TK; Muro S
    ACS Nano; 2013 Dec; 7(12):10597-611. PubMed ID: 24237309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria.
    Sarthou JL; Angel G; Aribot G; Rogier C; Dieye A; Toure Balde A; Diatta B; Seignot P; Roussilhon C
    Infect Immun; 1997 Aug; 65(8):3271-6. PubMed ID: 9234786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sera from patients with falciparum malaria induce substance P gene expression in cultured human brain microvascular endothelial cells.
    Chiwakata CB; Hort G; Hemmer CJ; Dietrich M
    Infect Immun; 1996 Dec; 64(12):5106-10. PubMed ID: 8945553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody.
    Przemioslo RT; Lundin KE; Sollid LM; Nelufer J; Ciclitira PJ
    Gut; 1995 Jun; 36(6):874-9. PubMed ID: 7615276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor in benign and malign tissue of the kidney.
    Bichler KH; Kleinknecht S; Nelde HJ; Strohmaier WL
    Urol Res; 1991; 19(6):367-73. PubMed ID: 1759331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor necrosis factor (TNF) and pathology; its relationships with other cytokines].
    Grau GE; Lambert PH; Vassalli P; Piguet PF
    Schweiz Med Wochenschr; 1989 Dec; 119(49):1756-61. PubMed ID: 2482541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis.
    Zhang K; Gharaee-Kermani M; McGarry B; Remick D; Phan SH
    J Immunol; 1997 Jan; 158(2):954-9. PubMed ID: 8993016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
    Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
    J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The beneficial effects of localized tumor necrosis factor production in BCG infection.
    Kindler V; Sappino AP
    Behring Inst Mitt; 1991 Feb; (88):120-4. PubMed ID: 2049028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential production of interleukin 1 (IL-1), IL-6, tumor necrosis factor, and IL-1 receptor antagonist by human monocytes stimulated with Mycobacterium leprae and M. bovis BCG.
    Suzuki K; Fukutomi Y; Matsuoka M; Torii K; Hayashi H; Takii T; Oomoto Y; Onozaki K
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):609-18. PubMed ID: 8151194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.